Location History:
- Memphis, TN (US) (2020 - 2024)
- Lexington, KY (US) (2023 - 2024)
Company Filing History:
4 out of 559 
4 out of 260 
4 out of 879 
Years Active: 2020-2025
Title: Innovations and Contributions of Inventor Jared T Hammill
Introduction
Jared T Hammill is a notable inventor based in Lexington, KY (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of 7 patents, Hammill has focused on developing innovative solutions for various medical conditions, particularly those related to neurodegenerative diseases and infections.
Latest Patents
Hammill's latest patents include groundbreaking work on pharmaceutically active pyrazolo-pyridone modulators of DCN1/2-mediated cullin neddylation. This invention provides a method for treating disorders associated with dysfunctional DCN1 and/or UBC12, including Alzheimer's disease, other neurodegenerative diseases, bacterial infections, and viral infections. The patent outlines a DCN1/2-mediated cullin neddylation modulator that includes a compound according to a specific formula. Additionally, Hammill has developed methods for treating cancers by administering a therapeutically effective amount of this compound. Another significant patent involves compositions and methods for treating malaria, utilizing tetrahydrobenzonaphtyridine carboxanilide (TBN) derivatives and related compounds that are effective against drug-resistant strains.
Career Highlights
Throughout his career, Hammill has worked with prestigious institutions such as Memorial Sloan Kettering Cancer Center and St. Jude Children's Research Hospital. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to cutting-edge research.
Collaborations
Hammill has collaborated with notable colleagues, including Daniel C Scott and Bhuvanesh Singh, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Jared T Hammill's innovative work and dedication to advancing medical treatments have made him a significant figure in the field of pharmaceuticals. His contributions continue to pave the way for new therapies that address critical health challenges.